Brazilian Nonproprietary Name

The Brazilian Nonproprietary Name or DCB, from the Portuguese Denominação Comum Brasileira is the official Portuguese nomenclature for drugs or active ingredients that have been approved by the Brazilian Health Regulatory Agency (ANVISA) for use in Brazil.[1][2] The consolidated list from October 2021 contains just over 12,300 items.[3]

Every record has a numerical identifier known as the DCB Number, used in contexts such as registrations, tenders and official documentation.[4][5]

History

In 1970 Andrejus Korolkovas, from the Faculty of Pharmaceutical Sciences, University of São Paulo, was already publishing about the importance of a nomenclature to harmonize the names of drugs.[6] In the year 1981, a list of generic names that would be mandatory for a new registration of a medicine was published in the Official Gazette of the Union, by the Ministry of Health. A standardization of nomenclature was carried out, and the introduction of numerical codes that would allow the identification of the substances. In 1983 the use of the standard nomenclature in official documents was made mandatory.[6]

See also

References
  1. "The Brazilian Pharmacopeia". Brazilian Health Regulatory Agency - ANVISA. 2020-11-03. Archived from the original on 2023-08-01. Retrieved 2023-08-01.
  2. da Fonseca, Elize Massard; Shadlen, Kenneth C (2017-02-08). "Promoting and regulating generic medicines: Brazil in comparative perspective". Revista Panamericana de Salud Pública. 41: 1. doi:10.26633/RPSP.2017.5. ISSN 1020-4989. PMC 6612747. PMID 28444005. S2CID 4909245.
  3. "Capa - Denominações Comuns Brasileiras". Agência Nacional de Vigilância Sanitária - Anvisa (in Brazilian Portuguese). Archived from the original on 2022-12-21. Retrieved 2023-08-01.
  4. "RESOLUÇÃO - RDC Nº 111, DE 29 DE ABRIL DE 2005 - ANVISA". Biblioteca Virtual em Saúde - Ministério da Saúde (in Brazilian Portuguese). 2005-04-29. Archived from the original on 2023-08-01. Retrieved 2023-08-01.
  5. M2Farma (2022-01-04). "Listas de DCBs atualizadas pela ANVISA 2022". Blog M2Farma (in Brazilian Portuguese). Archived from the original on 2023-06-04. Retrieved 2023-08-01.
  6. Anvisa. "DCB - Apresentação / Histórico" (in Brazilian Portuguese). Archived from the original on 2010-09-30. Retrieved 2010-02-13.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.